HomeProducts & ServicesNew Products > Stago applies its expertise in Haemostasis to bring a new platelet aggregation system solution to the market (1)

Stago applies its expertise in Haemostasis to bring a new platelet aggregation system solution to the market (1)

Back to list

Disorders of primary haemostasis caused by platelet or von Willebrand factor defects or deficiencies are relatively rare. Although specialists understand the pathologies well, most medical facilities lack the complex diagnostic equipment required to manage these patients; therefore, patients are typically referred to speciality care centres for diagnosis and treatment.

Stago, the Haemostasis expert, has joined forces with SD Innovation, a global instrument designer, to introduce a new easy-to-use solution specifically for the diagnosis of platelet disorders, the aggregometer. Introduction of the aggregometer expands access to medical facilities previously unable to care for such specialised patients enabling them to receive treatment sooner and be managed closer to home. 

The aggregometer is a complete system solution including the instrument and reagents. Five reagents, all CE marked for use on the SD Innovation aggregometer, were developed by the Stago Group subsidiary, Agro-Bio.

The easy-to-use aggregometer, employs an optimised measurement system for platelet aggregation at an infrared wavelength which reduces interference from haemolysis, icterus or lipaemia. Flexible for multiple workloads, 4-channel and 8-channel models are available (the TA-4V and TA-8V, respectively), together with the following Agro-Bio reagents: 

 

  • ADP (Cat. Nr. 86923)
  • Arachidonic Acid (Cat. Nr. 86922)
  • Collagen (Cat. Nr. 86924)
  • Epinephrine (Cat. Nr. 86925)
  • TRAP 6 (Cat. Nr. 86926)

The aggregometer is also compatible with research reagents and is suitable for the scientific study of Haemostasis.

(1) Availability depending upon the country

Top